Rafael Holdings Inc. operates as a holding company with a focus on healthcare and real estate. Its primary function is to invest in and support the development of biopharmaceutical ventures alongside managing a portfolio of commercial real estate properties. The company actively engages in the life sciences sector, where it holds interests in entities exploring innovative cancer and metabolic disease therapies. These ventures reflect its strategic aim to contribute to groundbreaking medical advancements. In addition to its biopharmaceutical interests, Rafael Holdings owns and oversees office buildings situated primarily in Newark, New Jersey. This dual focus on both healthcare innovations and real estate investments underscores the company's diversified business model. By balancing real estate stability with potential high-growth healthcare opportunities, Rafael Holdings positions itself uniquely within the financial market. It serves as a bridge between traditional real estate investment and cutting-edge biotech endeavors, leveraging its resources to create value across different sectors. As a public company, Rafael Holdings offers investors exposure to both tangible property assets and pioneering medical technology developments, reflecting its integral role in advancing healthcare solutions while maintaining a solid real estate foundation.